论文部分内容阅读
目的:探讨利凡诺联合米非司酮和米索前列醇用于中晚期妊娠引产的效果及安全性。方法:选取来我院要求引产的360例患者为分析对象,随机将其分为两组:利凡诺联合米非司酮和米索前列醇组(观察组)和利凡诺组(对照组),对利凡诺联合米非司酮和米索前列醇用于中晚期妊娠引产的临床疗效进行分析评价。结果:观察组在引产过程中,腹痛轻,出血少,胎盘胎膜残留少,总产程短,一次引产成功率为100%;对照组在引产过程中,腹痛很重,出血多,胎盘胎膜残留多,总产程长,一次引产成功率为89%。对比分析两组的治疗效果,观察组明显优于对照组,其差异具有统计学意义(p<0.05)。结论:利凡诺联合米非司酮和米索前列醇用于中晚期妊娠引产成功率极高,值得临床应用和推广。
Objective: To investigate the efficacy and safety of rivanol in combination with mifepristone and misoprostol for induction of labor in middle and late pregnancy. METHODS: A total of 360 patients who requested induction of labor in our hospital were selected and divided into two groups: Rivaroxel plus mifepristone and misoprostol (observation group), and rivanol group (control group ), The rivanol combined with mifepristone and misoprostol for the induction of labor in the second trimester pregnancy clinical evaluation. Results: The observation group in the induction of labor process, light abdominal pain, less bleeding, less residual placental membranes, shorter total length of labor, a successful induction of labor was 100%; control group in labor induction, heavy abdominal pain, bleeding, placental membranes Residues and more, the total length of production engineer, a successful induction of labor was 89%. By comparing the curative effect of the two groups, the observation group was significantly better than the control group, the difference was statistically significant (p <0.05). Conclusion: Rivanol combined with mifepristone and misoprostol for induction of labor in late pregnancy has a very high success rate, which is worthy of clinical application and promotion.